6855.HK
Ascentage Pharma Group International
HKSEHKDEQUITY
Healthcare
DELAYED
Last price
32.86
▼ 0.74 (2.20%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
38.00
Prev close
33.60
Day high
33.98
Day low
31.90
Volume
4.23M
Market cap
$12.27B
P/E (TTM)
—
52W range
30.00 – 91.50
Day trading desk
Gap from prior close
+13.10%
Prior close 33.60
VWAP
32.76
+0.31% from price
Relative volume
5.47×
Unusually busy
Session range
19.12%
31.90 – 38.00
Position in range
16%
Near session low
ATR (14D)
1.99
6.06% of price
Prior day high
36.34
PDH
Prior day low
32.10
PDL
Bid / ask spread
—
Quote not published
Session volume
14.83M
Avg 2.71M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-8.72%
-7.4%
1M
-11.67%
-15.4%
3M
-18.54%
-21.6%
6M
-29.15%
-40.2%
YTD
-37.47%
-49.8%
1Y
-58.03%
-78.0%
3Y
+43.18%
-31.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 6855.HK open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
84.88M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| May 23, 25 | Lippman (Marc E) Independent Non-Executive Director |
BUY | 6.37K | $167.60K | Direct |
| May 22, 25 | Lippman (Marc E) Independent Non-Executive Director |
BUY | 6.37K | $162.37K | Direct |
| May 21, 25 | Lippman (Marc E) Independent Non-Executive Director |
BUY | 6.37K | $159.44K | Direct |
| May 20, 25 | Lippman (Marc E) Independent Non-Executive Director |
BUY | 2.08K | $48.16K | Direct |
| Dec 27, 24 | Wang (Shaomeng) Director (Non-Executive) |
— | 10.05M | — | Direct |
| Dec 27, 24 | Yang (Dajun) Chief Executive Officer |
— | 23.09M | — | Direct |
| Dec 27, 24 | Zhai (Yifan) Divisional Officer |
— | 14.14M | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Lippman (Marc E) |
Independent Non-Executive Director | 21.17K | Acquisition |
Wang (Shaomeng) |
Director (Non-Executive) | 10.05M | Other |
Yang (Dajun) |
Chief Executive Officer | 23.15M | Other |
Zhai (Yifan) |
Divisional Officer | 14.26M | Other |
Fundamentals
Market cap$12.27B
Enterprise value$12.46B
Revenue (TTM)$642.64M
Gross profit$603.62M
EBITDA$-1.34B
Net income$-1.47B
EPS (TTM)$-4.60
Free cash flow$-974.30M
Total cash$1.90B
Total debt$2.09B
Book value / share$4.16
Shares outstanding373.35M
Float285.90M
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E-41.69
PEG ratio—
Price / sales—
Price / book7.89
EV / revenue19.39
EV / EBITDA-9.32
Gross margin93.93%
Operating margin-248.91%
Profit margin-228.54%
Return on equity-236.63%
Return on assets-28.04%
Debt / equity370.18
Current ratio1.22
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $574.12M | $980.65M | $221.98M | $209.71M | -41.5% |
| Operating revenue | $499.27M | $939.25M | $193.53M | $209.71M | -46.8% |
| Cost of revenue | $48.94M | $29.09M | $30.54M | $22.00M | +68.3% |
| Gross profit | $525.18M | $951.57M | $191.44M | $187.71M | -44.8% |
| Research & development | $1.14B | $947.25M | $706.97M | $743.10M | +20.1% |
| Selling, general & admin | $599.92M | $383.12M | $376.46M | $328.02M | +56.6% |
| Total operating expense | $1.72B | $1.32B | $1.06B | $1.04B | +30.4% |
| Operating income | -$1.20B | -$369.73M | -$872.64M | -$849.81M | -223.9% |
| Net interest income | $28.05M | -$26.61M | -$63.65M | -$43.06M | +205.4% |
| Pre-tax income | -$1.24B | -$395.25M | -$932.86M | -$887.17M | -212.7% |
| Tax provision | $6.94M | $10.43M | -$7.15M | -$4.25M | -33.4% |
| Net income | -$1.24B | -$405.43M | -$925.64M | -$882.92M | -206.5% |
| Net income to common | -$1.24B | -$405.43M | -$925.64M | -$882.92M | -206.5% |
| Basic EPS | -3.49 | -1.34 | -3.28 | -3.35 | -160.4% |
| Diluted EPS | -3.49 | -1.34 | -3.28 | -3.35 | -160.4% |
| EBIT | -$1.18B | -$330.80M | -$836.80M | -$834.39M | -257.3% |
| EBITDA | -$1.10B | -$237.63M | -$743.61M | -$771.47M | -361.0% |
| Basic shares | 356.13M | 302.06M | 282.30M | 263.69M | +17.9% |
| Diluted shares | 356.13M | 302.06M | 282.30M | 263.69M | +17.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $2.46B | $1.24B | $1.07B | $1.48B | +99.3% |
| Cash & short-term investments | $2.46B | $1.24B | $1.07B | $1.48B | +99.3% |
| Accounts receivable | $252.94M | $83.14M | $145.89M | $54.36M | +204.2% |
| Inventory | $28.62M | $6.60M | $16.17M | $9.45M | +333.8% |
| Total current assets | $2.94B | $1.47B | $1.34B | $1.64B | +99.7% |
| Property, plant & equipment | $829.25M | $905.86M | $957.23M | $650.02M | -8.5% |
| Goodwill & intangibles | $90.63M | $100.69M | $110.14M | $109.00M | -10.0% |
| Total assets | $3.96B | $2.62B | $2.50B | $2.83B | +51.4% |
| Total current liabilities | $1.64B | $1.17B | $934.17M | $881.15M | +40.9% |
| Current debt | $1.22B | $769.62M | $606.65M | $510.31M | +57.9% |
| Long-term debt | $742.33M | $868.64M | $1.17B | $1.27B | -14.5% |
| Total debt | $1.98B | $1.67B | $1.80B | $1.79B | +18.7% |
| Total liabilities | $2.63B | $2.34B | $2.43B | $2.42B | +12.2% |
| Retained earnings | -$7.01B | -$5.77B | -$5.37B | -$4.44B | -21.5% |
| Shareholder equity | $1.32B | $264.19M | $60.42M | $408.66M | +401.3% |
| Working capital | $1.30B | $307.55M | $410.00M | $755.34M | +323.0% |
| Net tangible assets | $1.23B | $163.50M | -$49.72M | $299.66M | +654.6% |
| Shares issued | 373.32M | 315.22M | 290.20M | 265.19M | +18.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$1.24B | -$395.25M | -$932.86M | -$887.17M | -212.7% |
| Depreciation & amortisation | $86.48M | $93.17M | $93.19M | $62.91M | -7.2% |
| Stock-based compensation | $20.87M | $20.92M | $31.50M | $22.11M | -0.2% |
| Change in working capital | -$143.50M | $110.97M | -$9.15M | $104.41M | -229.3% |
| Operating cash flow | -$1.17B | -$111.36M | -$726.08M | -$653.91M | -954.4% |
| Capital expenditure | -$27.57M | -$24.29M | -$56.84M | -$236.96M | -13.5% |
| Investing cash flow | -$1.00B | -$362.04M | $21.92M | -$384.61M | -176.2% |
| Share buybacks | -$9.04M | $0 | -$5.92M | -$26.78M | — |
| Dividends paid | $0 | $0 | $0 | $0 | — |
| Financing cash flow | $2.54B | $314.77M | $368.75M | $619.27M | +707.0% |
| Free cash flow | -$1.20B | -$135.65M | -$782.92M | -$890.88M | -785.9% |
| End cash position | $1.20B | $893.10M | $1.04B | $1.35B | +33.9% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-12-31 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $2.46B | $1.66B | $1.24B | +48.3% |
| Cash & short-term investments | $2.46B | $1.66B | $1.24B | +48.3% |
| Accounts receivable | $252.94M | $78.36M | $83.14M | +222.8% |
| Inventory | $28.62M | $8.59M | $6.60M | +233.1% |
| Total current assets | $2.94B | $1.91B | $1.47B | +54.2% |
| Property, plant & equipment | $829.25M | $871.96M | $905.86M | -4.9% |
| Goodwill & intangibles | $90.63M | $95.69M | $100.69M | -5.3% |
| Total assets | $3.96B | $3.05B | $2.62B | +30.1% |
| Total current liabilities | $1.64B | $1.24B | $1.17B | +32.6% |
| Current debt | $1.22B | $833.78M | $769.62M | +45.7% |
| Long-term debt | $742.33M | $882.38M | $868.64M | -15.9% |
| Total debt | $1.98B | $1.72B | $1.67B | +15.4% |
| Total liabilities | $2.63B | $2.37B | $2.34B | +10.9% |
| Retained earnings | -$7.01B | -$6.36B | -$5.77B | -10.2% |
| Shareholder equity | $1.32B | $666.00M | $264.19M | +98.9% |
| Working capital | $1.30B | $669.42M | $307.55M | +94.3% |
| Net tangible assets | $1.23B | $570.31M | $163.50M | +116.3% |
| Shares issued | 373.32M | 349.00M | 315.22M | +7.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $192.02M | — |
| Next quarter | — | — | $234.23M | — |
| Current year | -3.11 | 3 | $667.39M | +16.3% |
| Next year | -0.68 | 3 | $1.51B | +126.7% |
Analyst targets & ownership
Mean target$82.10
High target$108.11
Low target$43.95
Implied upside149.86%
Analyst count5
ConsensusSTRONG BUY
Strong buy / Buy1 / 5
Hold0
Sell / Strong sell0 / 0
Held by insiders22.76%
Held by institutions16.07%
Institutions holding63
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
35.38
-7.13% from price
SMA 20
34.86
-5.75% from price
SMA 50
34.82
-5.64% from price
SMA 100
39.14
-16.05% from price
SMA 200
46.51
-29.35% from price
EMA 12
34.78
-5.51% from price
EMA 26
35.12
-6.43% from price
EMA 50
35.94
-8.56% from price
RSI (14)
38.9
Neutral
MACD (12,26,9)
-0.34
Hist -0.21
ATR (14)
1.99
6.06% of price
Realised vol 30D
51.8%
Annualised
Bollinger upper
37.70
20, 2σ
Bollinger lower
32.03
20, 2σ
50 / 200 cross
Death
34.82 vs 46.51
Trend bias
Below 200
-29.35%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.08
Less volatile than market
Correlation to SPY
-0.02
Largely independent
Realised vol 30D
51.8%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-66.4%
Peak to trough
Max drawdown 5Y
-72.4%
Peak to trough
ATR 14
1.99
6.06% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Johnson & Johnson (JNJ) Wins EU Approval For TECVAYLI Combo In Multiple Myeloma
Simply Wall St. · 12m ago
Traeger (COOK) Stock Fair Value Rises After Q2 Margin Strength Lifts Analyst Targets
Simply Wall St. · 13m ago
Cigna Group (CI) Could Be 19% Undervalued As AI Spotlight Meets Growth Narrative
Simply Wall St. · 13m ago
Is Excelerate Energy (EE) Still Below Fair Value Following Its Recent Rally?
Simply Wall St. · 13m ago
Kane voted German footballer of the year
AFP · 14m ago
Asphalt Expert Robert Stewart Explains Asphalt Driveway Installation Preparation in HelloNation
PR Newswire · 17m ago
Is GE Vernova Under $1,000 a Bargain or a Trap? Here's the Honest Answer.
Motley Fool · 18m ago
The Idiot’s Guide to Stocks
24/7 Wall St. · 20m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.